AP:PSEAboitiz Power Corp. Analysis
Data as of 2026-06-14 - not real-time
$11.83
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The short‑term moving average sits above the intermediate average, which in turn is above the long‑term average, signaling a bullish alignment. The relative strength index remains in the upper‑mid range, suggesting momentum is still intact. The MACD histogram has slipped slightly negative, hinting at a potential short‑term pullback despite the overall bullish trend. Support sits comfortably above recent lows, while resistance near recent highs caps upside. Volatility is elevated, and beta is markedly higher than the market, indicating the stock swings sharply. The fair‑value estimate from discounted cash flow is well below the current price, pointing to a sizable valuation premium.
Fundamentally, the company posted modest top‑line growth but continues to generate a negative profit margin and carries a debt load that dwarfs its equity base. Cash balances are thin relative to debt, and return metrics are negative, underscoring financial strain. The ALP segment delivered strong earnings growth, yet the core forged products segment saw declining adjusted EBITDA, reflecting mixed operational performance. Analysts have not issued any consensus estimates, and the stock pays no dividend, limiting income appeal. Recent earnings released triggered a brief share decline, but a robust monthly rally has outpaced the broader market, driven by investor optimism in the growth segment. Given the juxtaposition of bullish technicals and weak fundamentals, the outlook hinges on whether the company can translate segment strength into overall profitability.
Fundamentally, the company posted modest top‑line growth but continues to generate a negative profit margin and carries a debt load that dwarfs its equity base. Cash balances are thin relative to debt, and return metrics are negative, underscoring financial strain. The ALP segment delivered strong earnings growth, yet the core forged products segment saw declining adjusted EBITDA, reflecting mixed operational performance. Analysts have not issued any consensus estimates, and the stock pays no dividend, limiting income appeal. Recent earnings released triggered a brief share decline, but a robust monthly rally has outpaced the broader market, driven by investor optimism in the growth segment. Given the juxtaposition of bullish technicals and weak fundamentals, the outlook hinges on whether the company can translate segment strength into overall profitability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish moving‑average crossover
- Elevated volatility and beta
- Recent strong monthly rally
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant valuation premium to DCF
- Weak profitability and high debt load
- Lack of dividend and negative return metrics
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Sustained overvaluation relative to fundamentals
- Structural financial strain from debt
- Uncertainty in translating segment growth to overall earnings
Key Metrics & Analysis
Financial Health
Revenue Growth3.90%
Profit Margin-15.53%
P/E Ratio51.4
ROE-104.73%
ROA1.53%
Debt/Equity291.61
P/B Ratio7.6
Op. Cash Flow$8.3M
Free Cash Flow$12.1M
Industry P/E30.6
Technical Analysis
TrendBullish
RSI58.3
Support$8.78
Resistance$12.11
MA 20$10.67
MA 50$10.19
MA 200$5.97
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$2.95
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.53
Volatility99.27%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.